Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 May 2019 | Story Igno van Niekerk | Photo Stephen Collett
Digital storytelling
Collaborating for the common good are from left: Willem Ellis, Karen Venter, Dr Deidre van Rooyen, Prof Hendri Kroukamp, Bishop Billyboy Ramahlele, and Dr Johan van Zyl.

Prof Hendri Kroukamp, Dean of the Faculty of Management Sciences quoted the Cat Stevens song I can’t keep it in, to capture the excitement surrounding the opening of a Digital Storytelling Lab on the Bloemfontein Campus on 10 May 2019.

After months of hard work by Dr Deidre van Rooyen, Willem Ellis, Karen Venter, as well as the staff of the University of the Free State’s (UFS) Centre for Development Support, the Common Good First lab was completed just in time for the launch attended by about 50 delegates from other South African universities, as well as private and public institutions.

Stories meet technology

In a message, from Prof Puleng LenkaBula, Vice-Rector: Institutional Change, Student Affairs, and Community Engagement, informed the audience that the launch heralded the joining of the old world of stories with the new world of digital technology. Julie Adair, Director of Digital Collaboration at Glasgow Caledonian University, Scotland, welcomed the UFS as a partner to this international social innovation collaborative project in a video message. 

Dr Van Rooyen, the project manager for the UFS, explained how she got involved in the Common Good First project, what the benefits of digital storytelling are, as well as what opportunities the lab creates for cooperation between role players involved in social innovation projects. 

Why the Common Good First lab?

The purpose of the lab is to create a digital network to identify, showcase and connect social innovation projects in South Africa to one another and to universities around the world for research, student engagement and learning and teaching. The lab has been fitted with state-of-the-art equipment for recording and digitising the stories that result from social innovation projects.

In a live Skype session with Dr Il-Haam Petersen, Postdoctoral Research Fellow at the Human Sciences Research Council (HSRC), and some of the recent successes of the digital stories in Philippi in the Western Cape were shared.

Bishop Billyboy Ramahlele, UFS Director Community Engagement did the final honours by cutting the ribbon, declaring the lab open, and sharing the dream that the work done in this lab will contribute to positive relationships and cooperation between the university and the community, in making not only the university, but the country and the world a better place.


News Archive

Meet Dr Olihile Sebolai, Prestige Scholar
2013-07-15

 

Dr Olihile Sebolai
Photo: Sonia Small
15 July 2013


Dr Olihile Sebolai, lecturer in the Department of Microbial, Biochemical and Food Biotechnology, was selected to the Vice-Chancellor’s Prestige Scholars Programme (PSP) in 2011. Dr Sebolai recently returned from a six month research visit to the University of Birmingham at the invitation of Professor Robin May, Lister Reader and Chair of Infectious Diseases.

This enabled Dr Sebolai to acquire and develop necessary pathobiological skills pertinent to his work on the pathogenesis of Cryptococcus neoformans. “During my time in Birmingham, I benefitted from the experiences of three senior post-doctorates and a principal investigator, who were all working in (Prof May’s) laboratory,” says Dr Sebolai.

“By way of observation, I was greatly impressed by the level of collaboration between Prof May and his network, which enables him to move out of a silo and effortlessly create a global footprint."

The next phase of Dr Sebolai’s early career development takes him as Fulbright Scholar to the University of Missouri in Kansas City, in September 2013. Here Dr Sebolai will spend time in the laboratory of Alexander Idnurm. The purpose of this visit is to study virulence mechanisms in fungi, which are a low order of eukaryotic organisms, and to identify potential drug targets.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept